Dynamk Capital — Full Portfolio
19 tracked investments · listed companies and verified rows first
Xcelthera develops cell therapy platform technology, serving the biotech and therapeutic development sector.
BiotechDeep TechHardwareHealthtechMedical Devices
Brian Feth(Chief Executive Officer)inJames Lim(Chief Scientific Officer)inShannon Eaker(Chief Technology Officer)in
Co-investorsAvego BioScience Capital
CellFE develops microfluidics technology and instrumentation for cell therapy manufacturing, serving biotech researchers and clinical teams.
BiotechDeep TechHardwareMedical DevicesAtlanta, US
Alla Zamarayeva, PhD(CEO & Co-founder)inTodd Sulchek, PhD(CSO & Co-founder)Alex Alexeev, PhD(Co-founder)Alla Zamarayeva(CEO & Co-founder)inTodd Sulchek(CSO & Co-founder)inAlex Alexeev(Co-founder)in
Co-investorsCota CapitalGreatPoint VenturesM VenturesEmbark VenturesKhosla Ventures
Abbelight provides microscopy equipment, reagents, and services to researchers and biotech labs for studying biology at the molecular level.
BiotechDeep TechHardwareMedical Devices
Jean-Baptiste Marie(CEO and Co-founder)inNicolas Bourg(CTO and Co-founder)in
BoardSandrine Lévèque-Fort(Scientific Advisor)Emmanuel Fort(Scientific Advisor)
Co-investorsAvant BioGENERAL INCEPTION
Alpenglow Biosciences develops AI-enabled 3D tissue imaging and spatial profiling platforms for researchers and clinical teams in pathology and diagnostics.
AI & Machine LearningBiotechDeep TechMedical Devices
Nicholas Reder(MD, MPH)inJonathan Liu(Co-founder)inAdam Glaser(Co-founder)inLarry True(Co-founder)
bit.bio is a synthetic biology company that engineers human induced pluripotent stem cells into defined cell types for research, drug discovery, and cell therapy applications.
BiotechDeep TechHealthtechMedical Devices
Dr Mark Kotter(Founder)Przemek Obloj(CEO)inEmma Pepperellin
Co-investorsForesite CapitalBlueYard CapitalARCH Venture PartnersGood AI CapitalHAWKTAILMetaplanet+2 more
Curi Bio provides a preclinical drug development platform combining 3D human tissue models of disease (cardiac and skeletal muscle), biosystems for functional analysis, and AI/ML-based insights to assess drug safety, efficacy, and potency.
AI & Machine LearningBiotechMedical Devices
Elliot Fisher(Cofounder)in
Envisagenics uses AI-driven analysis of RNA splicing to discover novel drug targets for immuno-oncology and neurodegenerative diseases.
AI & Machine LearningBiotechMedical DevicesNew York, US
Martin Akerman, PhD(CEO & Co-founder)Martin Akerman(Executive Officer, Director, Promoter)inMaria Luisa Pineda(Executive Officer, Director, Promoter)inMaria Luisa Pineda, PhD.(Founder)in
Co-investorsHAWKTAILM12 (Microsoft's Venture Fund)Madrona Venture GroupRed Cell IncubationDolby Family VenturesThird Kind Venture Capital
Wilbraham, US
Bart Lipkens(Executive Officer, Director)inStanley Kowalski(Executive Officer, Director)
BoardMichael Harsh(Director)inBoris Ryabov(Director)Kevin Delbridge(Director)Daniella Kranjac(Director)in
Co-investorsBright Capital
Lucid Scientific develops Resipher, a technology for live, continuous, and noninvasive monitoring of cellular oxygen consumption rate to study cell metabolism.
BiotechDeep TechHardwareAtlanta, US
Samuel Walker Inman(Executive Officer, Director)Ian W. Hunter(Executive Officer, Director)
BoardDr. Gustavo Mahler(Director)in
Co-investorsGRA VentureIAG Capital Partners
Nomic is an AI platform for architecture, engineering, and construction (AEC) teams that orchestrates agents across drawings, specs, submittals, RFIs, and building codes to automate coordination and review work.
AI & Machine LearningConstruction TechEnterprise Software
Brandon Duderstadt(Founder)in
Co-investorsBetaworksCoatue ManagementContrarySR One Capital Management2048 VenturesLux Capital
A stem cell tools and technology company providing standardized platforms to accelerate regenerative medicine development and clinical trials.
BiotechFrederick, US
Jon Rowley(Director)inTimothy Kelly(Executive Officer, Director)Margot Connor(Executive Officer, Director)Uplaksh Kumar(Chief Operating Officer)
BoardMartin Westberg(Director)Rob Carlson(Director)
Co-investorsMaryland TEDCOTEDCOVanedge CapitalVanedge Capital Limited PartnershipAvant Bio
Vectron Biosolutions develops custom bacterial production strains for protein manufacturing, using proprietary technologies (VB Expression, VB Evolution, and VB Secretion) to engineer E. coli and other microorganisms for clients in the pharmaceutical and biotech industries.
BiotechDeep TechTrondheim, NO
Svein Valla(Professor)Trond Erik Vee Aune(C.E.O.)in
Vernal Biosciences is an mRNA contract development and manufacturing organization (CDMO) that produces high-quality mRNA for research and therapeutic development.
Advanced ManufacturingBiotechDeep TechMedical DevicesColchester, US
Christian Cobaugh(Chief Scientific Officer and Founder)in
BoardErrik Anderson(Director)
Virica is a biotech company that develops small-molecule "Viral Sensitizers" which temporarily reduce host cell defenses during viral vector production to increase yield, quality, and scalability.
Advanced ManufacturingBiotechDeep TechHealthtechMedical DevicesOttawa, CA
Jean-Simon Diallo(Founder)inKen Newport(Executive Officer)inElla Korets-Smith(Executive Officer)in
Co-investorsAvant Bio
BiotechSan Francisco, US
Kaz Ohno(Executive Officer)James Lim(Executive Officer)Brian S. Feth(Executive Officer, Director)
BoardSaeid Akhtari(Director)
Co-investorsCasdin CapitalFormic VenturesViking Global Investors
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Bionter AGLightspeed MicroscopyRESIPHERXcell Bioscience
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.